Status:
COMPLETED
Distant Metastases and Long-Term Survival After Complete Resection of Neuroendocrine Tumors of the Appendix
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Neuroendocrine Tumors of the Appendix
Eligibility:
All Genders
Brief Summary
The aim of the present project is to evaluate the frequency of distant metastases and clinically relevant relapse and mortality, respectively, of aNEN (Neuroendocrine Neoplasms of the Appendix) measur...
Eligibility Criteria
Inclusion
- The investigators will include all patients with aNET measuring 1 - 2 cm and complete resection between 01.01.2005 and 31.12.2010 of the primary tumor.
Exclusion
- \-
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2022
Estimated Enrollment :
278 Patients enrolled
Trial Details
Trial ID
NCT03852693
Start Date
October 1 2020
End Date
August 30 2022
Last Update
November 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UHIBerne
Bern, Switzerland, 3010